# Influence of Aromatase Inhibition on Hepatic- and Cardiac Function in Severe Obese Men

> **NCT02097680** · PHASE4 · COMPLETED · sponsor: **University Hospital, Ghent** · enrollment: 30 (estimated)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Letrozole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02097680
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02097680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02097680, "Influence of Aromatase Inhibition on Hepatic- and Cardiac Function in Severe Obese Men". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02097680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*